Evidence map›Paper›PMID 26620370›Full record

ArticleEuropean journal of drug metabolism and pharmacokinetics2016

Enhancement of Dissolution Rate and Intestinal Stability of Clopidogrel Hydrogen Sulfate.

Dina E Bali, Mohamed A Osman, Gamal M El Maghraby

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in European journal of drug metabolism and pharmacokinetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Dina E BaliDepartment of Pharmaceutical Technology, College of Pharmacy, University of Tanta, Tanta, Egypt.
Mohamed A OsmanDepartment of Pharmaceutical Technology, College of Pharmacy, University of Tanta, Tanta, Egypt.
Gamal M El MaghrabyDepartment of Pharmaceutical Technology, College of Pharmacy, University of Tanta, Tanta, Egypt. gmmelmag@yahoo.com.
Tanta University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesClopidogrel is an antiplatelet and antithrombotic prodrug. It has poor oral bioavailability due to poor dissolution and possible premature degradation in the intestine. Accordingly, the objective of this study was to enhance clopidogrel dissolution rate and to reduce its premature degradation in rabbit intestine.

methodsSolid dispersion (SD) systems of clopidogrel with gelucire 50/13 and/or cremophor RH40 were prepared using fusion technique. The SD systems were characterized with respect to drug dissolution. The characterization included thermal analysis and infrared investigations. The stability of clopidogrel in the fluid extracted from small intestinal and colonic mucosal surfaces was monitored both in absence and presence of cremophor or gelucire.

resultsSD formation enhanced drug dissolution with the enhancement increasing at higher concentrations of either cremophor or gelucire. The ternary SD of clopidogrel with cremophor and gelucire reflected synergism between them. This synergism was manifested by enhanced dissolution efficiency of drug to reach 85 % at pH 6.8 and 89 % at pH 7.4 compared to unprocessed drug which liberated 16.2 and 15.2 % at the same pH values, respectively. Enhanced dissolution from SD was mainly due to micellar solubilization for cremophor and was due to change in the crystalline nature of drug with a contribution to self-emulsification in case of gelucire. Clopidogrel showed premature degradation in the intestinal fluid. Cremophor RH 40 reduced this degradation but gelucire failed in this respect.

conclusionThe study introduced SD system for enhanced dissolution rate of clopidogrel with a potential of reduced premature degradation in the intestine.

Indexed as

Drug CompoundingAnimalsBiotransformationCelluloseClopidogrelColonDrug LiberationDrug StabilityEmulsifying AgentsExcipientsFatsIntestinal MucosaIntestinal SecretionsIntestine, SmallIn Vitro TechniquesMicellesCelluloseClopidogrelcremophorEmulsifying AgentsExcipientsFatsGelucire 50-13MicellesOilsPharmaceutical VehiclesPlatelet Aggregation InhibitorsPolyethylene GlycolsProdrugsSilicon DioxideSuspensionsTiclopidine

Identifiers

PMID26620370
OpenAlexW2185135174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.